Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Keyphrases

• 30-day Mortality 37%
• 75 years or Older 12%
• Active Cancer 12%
• Adjusted Odds Ratio 12%
• All-cause Mortality 12%
• American Cancer Society 12%
• Anticancer Therapy 12%
• Anticancer Treatment 12%
• Azithromycin 12%
• Baseline Data 12%
• Breast 12%
• Canada 25%
• Cancer Diagnosis 12%
• Cancer Research 12%
• Cancer Treatment 25%
• Cancer Types 12%
• Clinical Conditions 12%
• Clinical Impact 100%
• Comorbidity 12%
• Confounding by Indication 12%
• COVID-19 100%
• De-identified Data 12%
• Disease Course 12%
• Eastern Cooperative Oncology Group Performance Status (ECOG PS) 12%
• Exclusion Criteria 12%
• Former Smokers 12%
• General Risks 12%
• High Status 12%
• Hydroxychloroquine 12%
• Increasing Age 12%
• Logistic Regression Analysis 25%
• Long Follow-up 12%
• Male Sex 12%
• Malignancy 12%
• National Institutes of Health 12%
• Non-associated 12%
• Obesity 12%
• Obesity Status 12%
• Partial Adjustment Model 12%
• Patients with Cancer 100%
• Potential Prognostic Factors 12%
• Previous Malignancy 12%
• Prognostic Factors 12%
• Prostate 12%
• Remission 12%
• Risk Factors 12%
• Severe Acute Respiratory Syndrome Coronavirus 2 Infection 12%
• Severe Disease 12%
• Smoking Status 25%
• Spain 12%
• US Midwest 12%
• US Northeast 12%

Medicine and Dentistry

• All Cause Mortality 37%
• Azithromycin 12%
• Cancer 25%
• Cancer Diagnosis 12%
• Cancer Research 12%
• Cancer Therapy 25%
• Cancer Treatment 12%
• Cancer Types 12%
• Cohort Analysis 100%
• Comorbidity 12%
• COVID-19 100%
• Disease Course 12%
• Diseases 12%
• Hydroxychloroquine 12%
• Independent Factor 12%
• Infection 12%
• Logistic Regression Analysis 25%
• Malignant Neoplasm 62%
• Odds Ratio 12%
• Oncology 12%
• Prognostic Factor 12%
• Severe Acute Respiratory Syndrome Coronavirus 2 12%